Bioidentical vs Synthetic Hormone Therapy: A Charleston Woman's Guide to Which Is Right

Ashley Harwyn, PA-C, ABAAHP  |  Published October 13, 2026  |  Last updated October 13, 2026  |  13 min read

What the labels hide, what the research actually shows, and how to choose with a clinician, from a Mount Pleasant PA-C.

That distinction gets blurred on purpose, because “bioidentical” sells. This page is the guide no hormone clinic in Charleston or Mount Pleasant publishes: what bioidentical actually means, how it differs from the older synthetic regimens and from compounded hormones, what the research says about safety, and how to choose the right option for you with a licensed clinician who reads your labs rather than your preferences.

• The decision that matters is FDA-approved versus compounded, not bioidentical versus synthetic. Both FDA-approved and compounded bioidentical hormones exist, and only one is regulated for purity and dose.[1]
• FDA-approved bioidentical options are real and widely used: transdermal or oral estradiol and oral micronized progesterone (Prometrium) are molecularly identical to your own hormones and are tested, labeled, and monitored.[1]
• Compounded bioidentical hormone therapy is not FDA-approved. The Menopause Society, ACOG, and the FDA all recommend FDA-approved formulations over compounded when an approved option exists.[1][2][3]
• “Synthetic” usually refers to the older Women's Health Initiative regimen, conjugated equine estrogens plus a synthetic progestin. Modern transdermal estradiol is a different drug with a different risk profile.[5]
• Roughly 1.0 to 2.5 million U.S. women age 40 and older use compounded hormones, often without being told they are unapproved.[4]
• In November 2025 the FDA removed the boxed “black box” warnings for heart disease, breast cancer, and dementia from FDA-approved systemic hormone therapy, a decision it framed as following the data.[6]

What “bioidentical” actually means, and why it is a marketing word

Bioidentical means a hormone is molecularly identical to the one your body makes, such as estradiol or progesterone. That is a chemistry fact, not a safety rating. The Menopause Society, the leading U.S. authority on menopause care, states plainly that the term “bioidentical hormone therapy (similar to endogenous) can be misleading because there are both government-approved and compounded bioidentical hormone therapies.”[1] In other words, the word tells you about structure, not about oversight.

Here is the part the marketing leaves out. The FDA-approved estradiol patch at your Mount Pleasant pharmacy is bioidentical. Oral micronized progesterone, sold as Prometrium, is bioidentical.[1] These are regulated products, tested in randomized trials, and dispensed with a label that lists the known risks. A compounded pellet marketed as “natural, bioidentical hormones” can contain the same estradiol molecule, yet carry none of that testing, labeling, or dose verification. Same molecule, completely different level of accountability.

So when a clinic frames the choice as “bioidentical hormones versus synthetic drugs,” it is selling a feeling. The question a careful clinician asks instead is whether the product is FDA-approved or compounded, because that is the line that actually predicts purity, consistent dosing, and honest risk disclosure.

Bioidentical, synthetic, and compounded: the comparison that matters

There are really three categories, not two, and lumping them into “natural versus synthetic” hides the one difference that affects your safety. The table below separates them by the things that matter: molecular structure, FDA oversight, whether purity and dose are verified, and what is actually printed on the label.

Read the table top to bottom and the pattern is clear. FDA-approved bioidentical hormones give you the structure people want and the oversight they assume comes with it. Compounded products give you the structure and the marketing, but not the oversight. The Menopause Society is direct about the trade-off: “Compounded bioidentical hormone therapy presents safety concerns, such as minimal government regulation and monitoring, overdosing and underdosing, presence of impurities and lack of sterility, lack of scientific efficacy and safety data, and lack of a label outlining risks.”[1]

Weighing hormone therapy in Mount Pleasant or downtown Charleston? The right start is a full lab panel, an FDA-approved option considered first, and compounding only when there is a real reason. See how we approach it on the bioidentical hormone therapy page, or call 843-981-0870 to talk it through.

What the research actually says about safety

The fear most women carry into this conversation comes from one study, and it was not testing bioidentical hormones at all. The Women's Health Initiative, stopped early in 2002, tested conjugated equine estrogens plus a synthetic progestin (medroxyprogesterone acetate) in women who averaged about 63 years old.[5] It reported a higher relative risk of breast cancer and heart events, and those headlines reshaped how a generation of women think about hormones.

The honest reading is more useful. The absolute increases were small, on the order of a handful of extra events per 10,000 women per year, and they were measured with an older, oral, synthetic regimen in women well past menopause, not with transdermal estradiol in a newly menopausal 51-year-old.[5] Timing, delivery route, and the specific hormones all change the picture. That is exactly why the “synthetic versus bioidentical” headline is too blunt to make your decision for you.

The regulatory ground has shifted to match the newer evidence. In November 2025 the FDA removed the boxed warnings for cardiovascular disease, breast cancer, and dementia from FDA-approved systemic menopausal hormone therapy, a change the agency framed around evidence rather than old fear. “Women and their physicians should make decisions based on data, not fear,” the FDA said in announcing the action.[6] The endometrial-cancer warning on estrogen-alone products stayed in place, because that risk is real and managed by adding progesterone. We covered that change in detail when it happened; this is the same principle applied to the bioidentical question.

What the major medical bodies recommend

When you strip away the marketing, the leading authorities agree, and they are not quiet about it. The American College of Obstetricians and Gynecologists states that custom-compounded products “should not be routinely prescribed when U.S. Food and Drug Administration-approved formulations exist,” and that clinicians “should counsel patients that FDA-approved menopausal hormone therapies are recommended for the management of menopausal symptoms over compounded bioidentical menopausal hormone therapy preparations.”[2] That is a recommendation, not a suggestion.

The reasoning is about oversight, not ideology. ACOG notes that “because of a lack of FDA oversight, most compounded preparations have not undergone any rigorous clinical testing for either safety or efficacy, so the purity, potency, and quality of compounded preparations are a concern,” and that “both underdosage and overdosage are possible.”[2] The FDA, citing the 2020 National Academies review, reached the same place: the Academies “determined there was a lack of rigorous evidence of safety and effectiveness” for compounded hormones and concluded that “their wide-spread use poses a public health concern.”[3]

The Menopause Society adds the line that matters most in a sales conversation: “patient preference alone should not be used to justify the use of compounded bioidentical hormone preparations, particularly when government-regulated bioidentical hormone preparations are available.”[1] Preference is a reason to talk. It is not a reason to skip oversight.

When compounded hormones are actually the right call

Compounded hormones are not banned, and a good clinician will reach for them in the right situation. The Menopause Society names the legitimate cases directly: an allergy to an ingredient in an FDA-approved product, or a dose or formulation that is not commercially available.[1] If your body cannot tolerate a component of the approved patch, or you need a strength that no manufacturer makes, compounding solves a real problem that oversight alone cannot.

What does not qualify is “it sounds more natural” or “I only want pellets.” Those are preferences, and the evidence says preference is not enough to accept a product with no verified dose and no labeled risks when an approved, equally bioidentical option sits on the shelf.[1] The distinction is simple in practice: compounding is a tool for the uncommon case, not the default for everyone who walks in.

This is also where pellets deserve a flag. Pellets are compounded, not FDA-approved, and they deliver a dose you cannot adjust once it is implanted.[1] They can be the right choice in specific hands for specific patients, but they are frequently sold as the standard, which is the opposite of how the evidence reads.

Choosing hormone therapy in Charleston and Mount Pleasant

The brand on the door matters less than how the clinician works. Across the Charleston metro, from Mount Pleasant to West Ashley to Daniel Island, the clinics that advertise “bioidentical hormones” range from careful medical practices to pellet-first operations that sell one protocol to everyone. The way to tell them apart is to ask three questions: Do you start with lab work and symptoms, or with a product? Do you reach for FDA-approved options first? And when you do compound, can you tell me exactly why this patient needs it?

At Solcara Health, hormone therapy for Charleston and Mount Pleasant women is built that way on purpose. We read your labs and your history first, we lead with FDA-approved bioidentical options because they are tested and labeled, and we compound only for the specific cases the evidence supports. That is the same standard the Menopause Society and ACOG describe, delivered inside a real clinical relationship rather than a membership that renews a pellet every few months. If you want to understand what treatment actually costs here before you start, our guide to what hormone therapy costs in Charleston breaks down the drivers.

The point is not that bioidentical is bad. The point is that “bioidentical” alone tells you nothing about whether the product is safe, consistent, and honest about its risks. FDA-approved versus compounded tells you all three.